Outcome of Board Meeting.

Results View source PDF Explain this filing

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹29365.00

prior close

₹29635.00

announcement price

In-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-1.0%+1.4% vs market

Pharmaceuticals peers, median of 156sector-1.1%+1.6% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Midcap 150 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.7

10m

+1.2

15m

+1.8

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5-1.0+1.4-1.1+1.6

Next day

-2.0-0.5-1.5-1.4-0.6

+0.5-0.0+0.5-2.2+2.6

+0.3+0.4-0.1-2.4+2.7

+0.8+1.2-0.4-1.2+2.0

+0.8+0.8-0.0-1.7+2.5

+1.0+1.6-0.6-1.8+2.7

15d

+0.2+1.3-1.0-4.3+4.5

-2.2-1.4-0.9-7.0+4.7

-3.2+1.7-4.9-5.2+2.0

-7.1-0.9-6.1-9.1+2.1

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Abbott India's board, meeting on November 6, 2025, approved unaudited financial results for Q2 FY26 and H1 FY26 (ended September 30, 2025). Revenue from operations for Q2 stood at Rs 1,757.15 crore, up 7.6% from Rs 1,632.67 crore in Q2 FY25. For H1 FY26, revenue rose to Rs 3,495.50 crore vs Rs 3,190.28 crore last year, a 9.6% increase. Profit after tax for Q2 grew to Rs 415.27 crore (from Rs 358.61 crore), while H1 PAT reached Rs 781.13 crore vs Rs 686.62 crore. EPS for Q2 stood at Rs 195.42. The statutory auditor Walker Chandiok & Co LLP issued a clean limited review report with no qualifications. Operating cash flow for H1 FY26 was healthy at Rs 521.94 crore.

Likely market impact

Steady double-digit profit growth and a clean audit report are positive for shareholders, signaling consistent operational performance. However, revenue growth in single digits (under 10%) suggests modest top-line momentum rather than acceleration.